↓ Skip to main content

Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, September 2001
Altmetric Badge

Mentioned by

patent
6 patents

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles
Published in
Cancer Chemotherapy and Pharmacology, September 2001
DOI 10.1007/s002800100324
Pubmed ID
Authors

C. Koch, S. Hahn, K. Rockwell, J. Covey, W. McKenna, S. Evans

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Greece 1 3%
France 1 3%
Unknown 27 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 37%
Student > Ph. D. Student 5 17%
Student > Doctoral Student 2 7%
Student > Bachelor 2 7%
Student > Master 2 7%
Other 5 17%
Unknown 3 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 23%
Medicine and Dentistry 6 20%
Biochemistry, Genetics and Molecular Biology 4 13%
Chemistry 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 5 17%
Unknown 4 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2022.
All research outputs
#7,856,604
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#688
of 2,501 outputs
Outputs of similar age
#13,431
of 39,506 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#2
of 10 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 39,506 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.